(Q40414736)

20 September 2017

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. (English)

1 reference

20 September 2017

1 reference

1 reference

1 reference

Christopher S Ambrose

series ordinal

2

1 reference

20 September 2017

1

Robert B Belshe

1 reference

20 September 2017

Tingting Yi

3

1 reference

PubMed ID

18611422

20 September 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

20 September 2017

1 reference

20 September 2017

26 Suppl 4

1 reference

20 September 2017

D10-6

1 reference

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.083

Live attenuated versus inactivated influenza vaccine in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.083

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.083

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.083

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.083

10.1016/J.VACCINE.2008.06.083

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

18611422